These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2857059)

  • 1. Beta blockers with intrinsic sympathomimetic activity.
    White WB
    Am Fam Physician; 1985 Jan; 31(1):115-8. PubMed ID: 2857059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL
    J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic consequences of intrinsic sympathomimetic activity and cardioselectivity in beta-blocker therapy for hypertension.
    Man in 't Veld AJ; Schalekamp MA
    Eur Heart J; 1983 Jul; 4 Suppl D():31-41. PubMed ID: 6137381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?
    Taylor SH; Silke B; Lee PS
    N Engl J Med; 1982 Mar; 306(11):631-5. PubMed ID: 6120457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in betablocking drugs in cardiovascular therapy.
    Iisalo E; Heikkilä J
    Ann Clin Res; 1988; 20(5):324-33. PubMed ID: 2905877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic characterization of a new beta-receptor blocker: mepindolol at rest, during ergometer exercise and in the isoproterenol study in comparison with practolol and pindolol.
    Boneli J
    Int J Clin Pharmacol Biopharm; 1977 Jul; 15(7):325-31. PubMed ID: 19363
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of intrinsic sympathetic activity of beta-blockers on SA and AV nodes in man.
    Leclercq JF; Rosengarten MD; Kural S; Attuel P; Coumel P
    Eur J Cardiol; 1981; 12(6):367-75. PubMed ID: 6113145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are we misunderstanding beta-blockers.
    Cruickshank JM
    Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do beta-blockers really increase peripheral vascular resistance? Review of the literature and new observations under basal conditions.
    Man in't Veld AJ; Van den Meiracker AH; Schalekamp MA
    Am J Hypertens; 1988 Jan; 1(1):91-6. PubMed ID: 2897200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of adrenergic beta-receptor blocking agents.
    Sannerstedt R
    Adv Clin Pharmacol; 1976; 11():70-8. PubMed ID: 25571
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of hypertension. I. new antihypertensive agents, pharmacologic and pharmacokinetic bases. Beta-adrenergic blockers and blood pressure lowering].
    Brunner H
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():75-86. PubMed ID: 26152
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
    Beckmann R; Müller B; Schröder G; Stock G
    Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemodynamic effects of antihypertensive drugs].
    Bellini G; Onesti G
    Minerva Med; 1978 Apr; 69(20):1389-400. PubMed ID: 26893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G; Middeke M; Mrowka C; Pötzl C; Renner W; Zoller W
    Med Klin (Munich); 1989 Feb; 84(2):81-5. PubMed ID: 2651861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of antihypertensive drugs.
    Itskovitz HD
    Am Fam Physician; 1983 Jun; 27(6):137-42. PubMed ID: 6134461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of beta-blockade with beta-1-selectivity or intrinsic sympathomimetic activity on some cardiorespiratory responses to exercise.
    Yonga GO; Oyuga HW; Njeru EK
    East Afr Med J; 1993 Jul; 70(7):405-8. PubMed ID: 7904931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta blockers and renal function: a reappraisal.
    Epstein M; Oster JR
    J Clin Hypertens; 1985 Mar; 1(1):85-99. PubMed ID: 2873206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockade in ischaemic heart disease--influence of concomitant ISA or alpha-blockade on haemodynamic profile.
    Silke B; Nelson GI; Ahuja RC; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():45-52. PubMed ID: 6359109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.